The recent 3.4% gain must have brightened CEO Sam Hupert's week, Pro Medicus Limited's (ASX:PME) most bullish insider
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 19 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Insider Ownership: Pro Medicus has significant insider ownership, with 51% of shares held by the top four shareholders, indicating strong alignment between management and shareholder interests. The CEO, Sam Hupert, is the largest shareholder with 23%.
Institutional Investors: While institutional investors hold 14% of the company, their presence adds credibility; however, reliance on them can be risky as large sell-offs may impact share prices. Retail investors own 37%, allowing them to influence company policies collectively.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
